Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression a review of clinical effectiveness and guidelines
Post-traumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and depression are psychiatric disorders that interfere with daily-life activities. In Canada, the prevalence of PTSD is approximately 12%, 2.6% for GAD and 8% for depression. Patients with mental health disorders usually req...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2014, 31 October 2014
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Post-traumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and depression are psychiatric disorders that interfere with daily-life activities. In Canada, the prevalence of PTSD is approximately 12%, 2.6% for GAD and 8% for depression. Patients with mental health disorders usually require pharmacological and/or psychological interventions such as cognitive-behavioral therapy, however approximately two-thirds of patients with major depressive disorder do not have adequate responses to conventional treatments. The purpose of this report is to review the clinical effectiveness of TMS for treating PTSD, GAD and depression, and to summarize the guidelines that are associated with the use of TMS for these conditions |
|---|---|
| Item Description: | Title from PDF caption title. - "CADTH Rapid Response Service." |
| Physical Description: | 1 PDF file (44 pages) illustrations |